@article{79a392a8c3e147b4a93055d9d06148fa,
title = "Reply to: “Cell Therapy for Huntington's Disease: Learning from Failure”",
keywords = "Huntington disease, cell therapy",
author = "Albin, {Roger L.} and Kordower, {Jeffrey H.}",
note = "Funding Information: R.L.A. has received grant support from the Parkinson's Foundation, Michael J. Fox Foundation, and the NIH (P50NS091856, R21NS114749, R25 NS089450, and P30AG053760). R.L.A. serves on the DSMBs for the M‐STAR (ICON/Biohaven), COMPASS (IQVIA/Biogen), and PASSPORT (IQVIA/Biogen) trials. R.L.A. has been a paid consultant for Takeda and the Michael J. Fox Foundation. J.H.K. has been a paid consultant for Seelos Inc, Inhibikase Inc., Brainstorm Inc, Clintrex Inc., Fuji‐Cellular Dynamics, and AbbVie. J.H.K. has received grant support from Biogen Inc, the Michael J. Fox Foundation, and AbbVie. Funding Information: R.L.A. has received grant support from the Parkinson's Foundation, Michael J. Fox Foundation, and the NIH (P50NS091856, R21NS114749, R25 NS089450, and P30AG053760). R.L.A. serves on the DSMBs for the M-STAR (ICON/Biohaven), COMPASS (IQVIA/Biogen), and PASSPORT (IQVIA/Biogen) trials. R.L.A. has been a paid consultant for Takeda and the Michael J. Fox Foundation. J.H.K. has been a paid consultant for Seelos Inc, Inhibikase Inc., Brainstorm Inc, Clintrex Inc., Fuji-Cellular Dynamics, and AbbVie. J.H.K. has received grant support from Biogen Inc, the Michael J. Fox Foundation, and AbbVie.",
year = "2021",
month = mar,
doi = "10.1002/mds.28500",
language = "English (US)",
volume = "36",
pages = "788--789",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "3",
}